Ozempic's Newest Miracle: Dramatically Cutting Dementia Risk
New research tracking 1.7 million diabetics shows the weight-loss drug slashes dementia risk by up to 70%.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
Why this matters
This cryptocurrency story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on DecryptRelated market context
This Nasdaq-listed Bitcoin treasury diluted shareholders 18-fold to survive a $212 million crypto loss without selling its stash
GD Culture Group reported a $211.8 million first-half unrealized Bitcoin loss on its holdings while its split-adjusted share count...
Trump-linked World Liberty Financial wins OCC bank approval as $112 million DeFi position sits near liquidation
The Office of the Comptroller of the Currency (OCC) gave World Liberty Financial, a DeFi venture associated with President Donald...
XRP Price Prediction: XRP Risks $0.97 as Price Remains Trapped Below Key EMAs
The weakness has left the XRP price vulnerable to another decline, with technical levels around $0.99 and $0.97 emerging as import...
Institutional investor Paul Tudor Jones adds 109,446 BlackRock Bitcoin ETF shares while cutting calls by 85%
Tudor Investment reported 18.9% more direct shares in BlackRock's iShares Bitcoin Trust ETF at June 30 than it held three months e...
Strategy tells MSCI ‘Bitcoin doesn’t need you’ as $2.8 billion index risk hangs over MSTR
Strategy faces a renewed threat of removal from major MSCI equity indexes under a broader screening proposal that could trigger an...
Over 1.3 million staked tokens remain stranded onchain after a major validator missed its deadline to exit Aztec
DV Labs’ planned Aug. 15 Aztec exit was still incomplete by 2 a.m. UTC on Aug. 16: seven DV Labs-listed attesters remained in the...